Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose IVIG therapy during pregnancy for women with prior neonatal hemochromatosis
jRCT1091220353Completed
- Sponsor
- National Center for Child Health and Development
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of immune globulin in neonatal hemochromatosis (NH), sponsored by National Center for Child Health and Development. Started Jun 2018; status: completed.
02
Drugs
immune globulin
03
Conditions
neonatal hemochromatosis (NH)
Beyond the preview
Go deeper on jRCT1091220353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220353.